Target intelligence / Profile preview

L antigen family member 3 pseudogene 1 (LAGE3P1)

Target
LAGE3P1
Molecular classification
Other (Pseudogene)
01

Overview

L antigen family member 3 pseudogene 1 (LAGE3P1) is annotated as a **pseudogene** and does not encode a functional protein product[1]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they typically arise from duplication or retrotransposition but lack essential regulatory or coding capacity[2][4]. LAGE3P1 is related by sequence homology to L antigen family member 3 (LAGE3), which itself is a bona fide protein-coding gene involved in the KEOPS complex and implicated as a biomarker and modulator in various cancers[3][5]. However, LAGE3P1, as a pseudogene, does not have verified biological function, molecular activity, or disease role and is not considered a therapeutic target[1].\n\n**Key context:** \n- LAGE3P1 is not a functional protein, receptor, enzyme, or therapeutic target based on current human genome annotation[1].\n- Pseudogenes can, in rare cases, have non-coding regulatory functions (e.g., acting as miRNA sponges), but there is no evidence LAGE3P1 specifically has such a role in disease or therapy[2].\n- The functional, disease-relevant protein is L antigen family member 3 (LAGE3), not LAGE3P1[3].\n\nIf you are seeking information about a **true protein-coding gene** implicated in cancer and potential therapeutic targeting, you may be referring to **L antigen family member 3 (LAGE3)** rather than LAGE3P1.

Beyond the preview

Go deeper on L antigen family member 3 pseudogene 1 (LAGE3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L antigen family member 3 pseudogene 1 (LAGE3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call